Introduction
The Gleason grading system, based on the architectural patterns of prostatic adenocarcinoma, has been an important prognostic tool, guiding management decisions for more than 40 years [1] . The Gleason grading system has been extensively modified over the years, following the emergence of survival data from several large cohorts, with the International Society of Urological Pathology (ISUP) introducing the most significant changes in 2005 and 2014 [2, 3] .
Several studies showed that the ISUP 2005 modification of the Gleason grading system was a better predictor of seminal vesicle invasion, lymph node metastases and clinical outcomes compared with the original Gleason grading system, but other studies found either no improvement or reduced predictive value [4] [5] [6] [7] [8] . In addition, universal acceptance was lacking with regard to the classification of the cribriform glands because the subjective criteria used were susceptible to interobserver variability [3, 9] . Currently, the introduction of active surveillance for low-volume Gleason score (GS) 6 cancers has made accurate and reproducible distinction between Gleason patterns 3 and 4 critical [10, 11] .
In light of the above, the ISUP convened a consensus conference in November 2014, and recommended that all cancers with cribriform and glomeruloid structures should be classified as Gleason pattern 4 and all variant forms of prostatic adenocarcinoma, for example, carcinoma with a prominent mucinous component, should be graded on their architectural growth pattern. In addition, the basis for a new grading system was proposed, based on data from Johns Hopkins Hospital published in 2013, resulting in five prognostically distinct Grade Groups [3, 12] . As per the 2014 ISUP grading system (referred to as Grade Groups in the 2016 WHO Classification), prostatic adenocarcinomas are graded on a scale of 1 to 5 where: Grade Group 1 includes GS <6 cancers; Grade Group 2 includes GS 3 + 4 = 7 cancers; Grade Group 3 includes GS 4 + 3 = 7 cancers; Grade Group 4 includes GS 4 + 4 = 8, 3 + 5 = 8 and 5 + 3 = 8 cancers; and Grade Group 5 includes GS 9 and 10 cancers, with a combination of Gleason patterns 4 and 5 [3, 13] . The 2014 ISUP grading system, therefore, differs from the 2005 modification of the original Gleason system in two significant areas: (1) it acknowledges that GS 7 combines two different patient cohorts with distinct survival outcomes requiring separate stratification [14] and (2) in its current format, it does not account for a component of Gleason pattern 5 cancer constituting a lower proportion than the primary or secondary patterns (tertiary pattern) in radical prostatectomy (RP) specimens [3] . The role of the tertiary pattern is not clearly defined in the currently proposed ISUP 2014 grading system [3] .
We aim to validate the association between 2014 ISUP grading of localized prostate cancer (PCa) and biochemical recurrence (BCR)-free survival in a cohort of patients undergoing RP at a large tertiary cancer hospital. The secondary aims were: (1) to assess the association between the 2014 ISUP grading system and clinical recurrence (CLR); (2) to investigate whether incorporation of the tertiary pattern into the ISUP scoring system significantly improved its efficacy; and (3) to investigate whether the 2014 ISUP grading system is a better predictor of survival as compared to the Gleason scoring system using Harrell's c-indices [15] .
Patients and Methods
Details of patients undergoing RP (1991-1999) were obtained after institutional human research ethics committee approval (ethics approval: St Vincent's Hospital File Number H00/088) to establish a consecutive cohort of patients with up to 15 years follow-up. All of the patients were treated in a single urology department at a tertiary hospital (St Vincent's Hospital, Sydney, NSW, Australia) using similar surgical techniques. Patients were excluded from the study cohort if they had received neoadjuvant hormone therapy. The final study cohort included 635 patients for whom complete clinical follow-up was available and archival slides and blocks were available for review.
All tissue from the RP specimens was submitted for processing and histological examination. The original (1992) GS, either reported in the pathology report or in prior regrading of cases before 2005, was recorded [16] . Relevant histopathology data regarding margin status, extraprostatic extension, seminal vesicle invasion, lymph node involvement, pTNM stage (American Joint Committee on Cancer 2010) were extracted from the database. The histopathology sections were reviewed by three uropathologists (J.G., R.G. and J.G.K.) blinded to the original GS and patient outcomes. All cases were assigned a GS, including a primary and secondary pattern/grade and, if present, a tertiary pattern, as per the 2005 ISUP modification of the Gleason grading system [2] . Tertiary pattern was defined as the third most common/prevalent pattern, provided that it was a higher grade than the primary and secondary patterns, and its percentage was recorded. Where the RP specimens contained more than one separate tumour nodule, each was scored separately, with the highest grade nodule being recorded as the score for that case. All cases were also assigned a Grade Group (referred to as ISUP Grades in some publications) in line with the recommendations of the 2014 ISUP Consensus Conference [3] . It has been standard practice of the uropathologists involved in this study to consider all glomeruloid and cribriform structures as Gleason pattern 4 as well as to grade mucinous adenocarcinomas based on the underlying architectural patterns for several years. Thus, there were no significant differences in assigning Gleason patterns 3 and 4 for the two systems. The 2014 ISUP grading system scores were assigned in two different ways: 1) using the primary and secondary patterns as recommended in the histological definitions of the new grading system (Table 5 of the ISUP Consensus Conference report [3] ) as version 1 to assess the primary aim of the study; and 2) replacing the secondary pattern with the tertiary pattern for assigning Grade Group as version 2 for evaluation of the secondary aim of the study. Discrepancies in grading were resolved by consensus microscopy.
Clinicopathological data were obtained. Patients were followed postoperatively by their surgeons on a monthly basis until satisfactory urinary continence was achieved and then at 3-month intervals for the first year, at six-monthly intervals up to 5 years, and yearly thereafter. The primary endpoint, BCR, was defined as a serum PSA concentration ≥0.2 ng/mL increasing over a 3-month period. Secondary endpoints were CLR, as determined by biopsy-confirmed local recurrence and/or a positive scan confirming bony or visceral metastasis. Death data were obtained from the New South Wales State Cancer Registry and the patients' GPs were also contacted, where possible, to ensure accuracy in the attribution of cause of death. Time to BCR and CLR were defined as the intervals between RP and the event. PCa-specific death was measured from the date of RP to confirmed date of death from PCa.
Statistical Analysis
The relationships between pathological scoring (Gleason system 1992/ISUP 2005 modified Gleason/ISUP 2014 grading system) and BCR-free survival, CLR-free survival and PCaspecific mortality were examined using log-rank and KaplanMeier analyses. Chi-squared testing was used to assess the correlation between pathological scoring and categorical clinicopathological variables. Gleason scores were analysed as categorical variables using all attainable scores. The 2014 ISUP grading system was analysed in both the formats described above to evaluate the primary and secondary aims of the study.
Univariable and multivariable analyses were performed using Cox proportional hazards modelling. Clinicopathological covariables known to influence BCR/CLR were modelled as continuous, dichotomous or trichotomous variables as appropriate. Variables were included in the multivariable Cox proportional hazards model if they had P values <0.10 on univariable testing. A P value <0.05 was taken to indicate statistical significance and all reported P values were twosided. Statistical analyses were performed using SPSS software version 23 (IBM).
Harrell's concordance c-indices were calculated using STATA/SE version 9.2. Harrell's c-index is a measure of the predictive discrimination of a model for a time-dependent outcome [15] . A c-index of 0.5 indicates no predictive accuracy, while a perfect model would have a c-index of 1 [15] .
Results
The study includes 635 patients who underwent RP and the clinicopathological characteristics of this cohort are summarized in Table 1 . At a median (range) follow-up of 15.25 (0.3-26) years, BCR was observed in 276 patients (44%) and CLR was observed in 41 patients (7%). There were 207 deaths (33%), of which 36 (6%) represented documented PCa-specific deaths. The ISUP 2014 grading system demonstrated a mismatch with the original 1992 Gleason grading in 407 patients (64%) in the cohort with a majority of discordant cases (53%) being upgraded ( Table 1 ).
The cohort in the present study had similar characteristics on univariable analysis to those recorded in other localized PCa series (Tables 2 and 3) . On univariable analysis, higher risk of BCR was associated with higher Grade Group (P < 0.001), older age at surgery (P = 0.01), higher preoperative PSA (P < 0.001), extraprostatic extension (P < 0.001), seminal vesicle invasion (P < 0.001), involved surgical margins (P < 0.001), and higher pT stage (P < 0.001; Table 2 ). Higher risk of CLR was associated with Grade Groups 3-5, higher preoperative PSA concentration (P < 0.001), extraprostatic extension (P < 0.001), seminal vesicle invasion (P < 0.001), involved surgical margins (P = 0.007), and higher pT stage (P < 0.001; Table 3 ).
Log-rank and Cox regression analysis were performed to evaluate the association between the 2014 ISUP grading system and BCR-free survival, CLR and PCa-specific death ( Fig. 1 and Tables 2 and 3) . Log-rank analysis showed that the survival curves for BCR separated more cleanly using the ISUP 2005 modified Gleason system compared with the 1992 Gleason scoring system (Fig. 1A,B) ; however, the 2014 ISUP grading system, as currently recommended, demonstrated a further refinement in prognostic capacity with the wide separation of the survival curves for Grade Group 2 (GS 3 + 4 = 7) and Grade Group 3 (GS 4 + 3 = 7) for BCR (Fig. 1B,C) .
There was a similar trend towards improved prognostication for CLR (Table 3) , where, again, the survival curves for CLR separate more cleanly by ISUP 2005 modified Gleason system compared with the 1992 Gleason system (Fig. 1E,F) . Grade Group 3 (GS 4 + 3 = 7) and Grade Group 4 (GS 8) shared a similar prognosis (Fig. 1G) . Grade Group 5 (GS 9 or 10) carried the greatest risk of recurrence (Fig. 1F,G) . Furthermore, the analysis of the PCa-specific death data based on the 1992 system demonstrates some subclassification of GS 8-10 vs ≤7 (Fig. 1I) ; however, a significantly higher risk of death from PCa was observed in men with ISUP 2005 modified Gleason score ≥9 and Grade Group 5 cancers (Fig. 1J,K) .
Multivariable analysis was performed for both BCR and CLR (Tables 2 and 3 ). The Grade Groups were an independent predictor of BCR when modelled with preoperative PSA (P < 0.001), surgical margin involvement (P = 0.06) and 0  50  100  150  200  250  300  0  50  100  150  200  250  300  0  50  100  150  200  250  300   0  50  100  150  200  250  300  0  50  100  150  200  250  300  0  50  100  150  200  250  300   0  50  100  150  200  250  300  0  50  100  150  200  250  300  0  50  100  150  200  250 Table 3 ). Only Grade Group 5 (P = 0.02) was an independent predictor of CLR when modelled with preoperative PSA (P < 0.001), surgical margin involvement (P = 0.06) and pathological stage (P < 0.001; Table 3 ).
Harrell's c-indices show that the 2014 ISUP grading system was a significantly better predictor of BCR, CLR as well as PCa-specific death compared with the 2005 modified Gleason scoring system (Table 4) .
Tertiary pattern 5 was present in 23 cases, ranging from <5% (in 12 cases) up to 20%. Replacement of the secondary pattern by the tertiary pattern, when tertiary pattern 5 of any extent was present (ISUP 2014 grading system version 2, Tables S1 and S2) resulted in an upgrade from Grade Group 2 or 3 to Grade Group 4 or 5 in 23 patients, while, if a threshold of >5% tertiary pattern 5 was applied, 11 cases were upgraded from Grade Group 2 or 3 to Grade Group 4 or 5 (Tables S3 and S4 ). Univariable and multivariable analyses performed after substituting the tertiary pattern for the secondary pattern (both with and without >5% threshold) showed that higher Grade Group was associated with increased risk of BCR and CLR (Tables S1-S4 ). The log-rank analyses showed a similar association of Grade Group incorporating tertiary pattern with BCR (Fig. 1C,D) and CLR (Fig. 1G,H) , as observed for ISUP 2014 grading without the tertiary pattern. While the numbers are too few for meaningful statistical analyses, there were no significant differences in BCR (P = 0.7) or CLR (P = 0.3) between the two versions of the ISUP 2014 grading system, nor between scoring with and without a threshold of >5% pattern 5.
Harrell's c-indices showed that the version incorporating the tertiary pattern in the score was a slightly better predictor of outcomes as compared with the currently accepted 2014 ISUP grading system (with tertiary pattern separately specified); however, this did not achieve statistical significance, possibly because only 23 patients (4%) were upgraded after the incorporation of the tertiary pattern in the present dataset.
Discussion
The data in the present study show that the ISUP 2014 grading system (referred to as Grade Groups in the 2016 WHO Classification [13] ) has superior capacity to predict BCR, CLR and PCa-specific death compared with the 1992 Gleason and ISUP 2005 modified Gleason grading systems. The risk stratification remained similar in both the currently recommended ISUP 2014 grading scheme, and when the tertiary pattern was taken into account.
Numerous refinements and modifications have been made to the Gleason grading system over the past 40 years, including major changes stemming from the 2005 and 2014 ISUP consensus conferences [2, 3] . Some of the key recommendations at both the 2005 and 2014 conferences were based on cohorts with relatively limited follow-up, for instance the median follow-up after RP in the largest published cohort was 3.0 years [3] [4] [5] 8, 12, 14] . The present study uses data accrued from a large cohort of patients who had prolonged follow-up after their RP (median >15 years), to demonstrate the validity of the key changes to the grading of PCa proposed at the 2014 ISUP Consensus Conference on Gleason Grading of Prostatic Cancer. The Grade Groups were significantly associated with BCR after RP, and stratified patients into robust prognostic groups. In particular, the present series showed a wide separation of the survival curves for Grade Group 2 vs 3, reflected in the corresponding hazard ratios that were approximately twofold higher for Grade Group 3 than 2. The present data show that GS 3 + 4 = 7 (Grade Group 2) and GS 4 + 3 = 7 (Grade Group 3) are separate cohorts with distinctly different prognoses.
Most studies assess only BCR, while our long-term follow-up allowed us to evaluate the critical endpoint of clinical relapse, which better reflects the potentially lethal form of PCa. Grade Groups 3, 4 and 5 cancers were associated with a poorer prognosis on univariable analysis while Grade Group 5 was an independent predictor of CLR on multivariable analysis. Likewise, only Grade Group 5 demonstrated a significantly higher risk of PCa-specific death, probably because of an insufficient number of events for subgroup analysis. The relatively small number of cases with CLR or PCa-specific death is a limitation of the present study; however, in practice it is a difficult one to avoid, given the long natural history of PCa and the low rate of PCa-specific death vs overall mortality in elderly men [17] . The present series comprised patients who underwent RP at a tertiary cancer centre and had complete median follow-up of 15 years for clinically relevant endpoints. Statistical modelling, in particular Harrell's c-indices, also shows the predictive ability of 2014 ISUP grading system in our cohort [15] . Our findings complement other recently published studies following the 2014 ISUP-convened consensus conference. In a series of 20 845 men treated by RP at five academic institutions with a median follow-up of 3 years, Epstein et al. [14] reported a significant difference in BCR rates between Grade Group 2 (GS 3 + 4 = 7) and Grade Group 3 (GS 4 + 3 = 7) and between Grade Group 4 (GS 8) and Grade Group 5 (GS 9 and 10) [14] . Two other single-institution studies of men treated by RP showed a significant correlation between Grade Groups and BCR, but one had a relatively short median 3.6 years' follow-up, while the other did not include histological review of their cases graded prior to 2005 (50% cases) and found that the new system was more accurate when applied to the post-2005 part of their cohort [18, 19] . A third study of 496 men followed for a minimum of 6.5 years, showed that the ISUP 2014 grading system outperformed the ISUP 2005 modified Gleason grading system for predicting BCR, metastasis and PCa-specific death [20] ; however, this latter cohort comprised men with locally advanced disease treated by radiotherapy and androgen deprivation; 31% of patients had a pre-treatment PSA >20 ng/mL and 33.7% of patients had ISUP 2014 category 4 or 5 cancer. Thus, the applicability of the findings of that study to PCa in a general population is uncertain. Finally, Berney et al. [21] have recently published data in a conservatively managed needle biopsy cohort validating the utility of the five-GradeGroup system in predicting death from PCa. Interestingly, in their Kaplan-Meier curves there was some overlap between Grade Groups 3 and 4 when using the 'overall grade', i.e. averaging all the needle biopsy cores as the grade for the case, but when using the 'worst grade' on biopsy as the grade for the case there was better separation between Grade Groups 3 and 4.
The retrospective nature of the present study has some inherent limitations. First, there was a 47% positive margin rate which is higher than would be expected in a modern cohort, but it is in line with PSM rates reported in the 1990s when these men underwent RP [22] . There has been a decreasing rate of PSMs since then, both in our cohorts and internationally [23] . Secondly, the 2005 ISUP-modified Gleason grading system was itself modified by the uropathologists involved in the present study who have considered all glomeruloid and cribriform structures as Gleason pattern 4, as well as grading mucinous adenocarcinomas based on the underlying architectural patterns, for several years following publication of data clarifying these issues [24, 25] . This has had the effect of reducing some of the difference between the 2005 and 2014 grading systems.
The handling of tertiary patterns/grades in RP specimens was also not resolved at the 2014 ISUP Consensus Conference, although this issue was discussed. In a subsequent review article, Kryvenko and Epstein [26] proposed that tertiary pattern 5 should be incorporated into the Grade Group for RP specimens when it occupies an area >5% of the tumour; however, at present, there is limited published evidence to support this proposal and its application is somewhat controversial. A tertiary Gleason pattern 5 was observed in 23 patients in our cohort. The replacement of the secondary pattern by the tertiary pattern did not alter the prognostic efficacy of the ISUP 2014 grading system; however, a subgroup analysis was not possible because of the relatively small numbers, and further data are required to determine the true biological relevance of tertiary patterns in RP specimens.
In conclusion, the data from our surgical series of 635 men treated at a tertiary cancer centre with long-term follow-up after RP, supports the role of ISUP 2014 grading in risk stratification and provides evidence for the validity of the changes to the grading of prostatic adenocarcinoma made at the 2014 ISUP Consensus Conference on Gleason Grading of Prostatic Carcinoma. 
